Log In
Print
BCIQ
Print
Print this Print this
 

Methylene Blue MMX (CB-17-01)

  Manage Alerts
Collapse Summary General Information
Company Cosmo Pharmaceuticals S.A.
DescriptionOral colon-release formulation of methylene blue delivered using MMX multi-matrix system technology
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase III
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose lesions, polyps and adenomas in the colon
Regulatory Designation U.S. - Special Protocol Assessment (Diagnose lesions, polyps and adenomas in the colon)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today